JP Morgan Chase
CELG

JP Morgan Chase’s Celgene Corp CELG Stock Holding History

JP Morgan Chase’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-348,200
Closed -$34.6M – 6128
2019
Q3 		$34.6M Buy
348,200
+50,000
+17% +$4.75M 0.01% 1173
2019
Q2 		$27.5M Sell
298,200
-660,200
-69% -$62.7M 0.01% 1336
2019
Q1 		$90.4M Buy
958,400
+173,500
+22% +$15.2M 0.02% 688
2018
Q4 		$50.3M Buy
784,900
+274,800
+54% +$20.3M 0.01% 895
2018
Q3 		$45.6M Buy
510,100
+339,800
+200% +$30M 0.01% 1063
2018
Q2 		$13.5M Sell
170,300
-117,700
-41% -$9.77M ﹤0.01% 1903
2018
Q1 		$25.7M Sell
288,000
-171,200
-37% -$16.4M 0.01% 1342
2017
Q4 		$47.9M Buy
459,200
+177,600
+63% +$20M 0.01% 1010
2017
Q3 		$40.2M Buy
281,600
+64,100
+29% +$8.73M 0.01% 1061
2017
Q2 		$28.2M Sell
217,500
-22,905
-10% -$2.81M 0.01% 1225
2017
Q1 		$29.9M Sell
240,405
-45,495
-16% -$5.44M 0.01% 1209
2016
Q4 		$33.1M Buy
285,900
+75,866
+36% +$8.45M 0.01% 1144
2016
Q3 		$22M Buy
210,034
+29,715
+16% +$3.22M 0.01% 1316
2016
Q2 		$17.8M Sell
180,319
-46,381
-20% -$4.8M ﹤0.01% 1475
2016
Q1 		$22.7M Buy
+226,700
New +$23.3M 0.01% 1258
2015
Q3 		– Sell
-25,000
Closed -$2.89M – 4337
2015
Q2 		$2.89M Buy
25,000
+23,300
+1,371% +$2.66M ﹤0.01% 2699
2015
Q1 		$196K Sell
1,700
-89,400
-98% -$10.7M ﹤0.01% 3833
2014
Q4 		$10.2M Sell
91,100
-51,600
-36% -$5.44M ﹤0.01% 1932
2014
Q3 		$13.5M Buy
+142,700
New +$12.9M ﹤0.01% 1711
2013
Q4 		– Sell
-35,520
Closed -$2.74M – 4507
2013
Q3 		$2.74M Hold
35,520
– – ﹤0.01% 2596
2013
Q2 		$2.08M Buy
+35,520
New +$2.14M ﹤0.01% 2775

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $8.4B AUM 51.89% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $488M AUM 17.59% 1-Year Est. Return

JP Morgan Chase's CELG Position: Q4 2019 in Review

JP Morgan Chase sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 9,354,501 shares — an estimated $929M sold.

JP Morgan Chase first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $2.54B in Q4 2015. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • JP Morgan Chase reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • JP Morgan Chase sold 9,354,501 Celgene Corp shares in Q4 2019, an estimated $929M.
  • JP Morgan Chase first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • JP Morgan Chase's Celgene Corp position peaked at $2.54B in Q4 2015.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on JP Morgan Chase's 13F filing for Q4 2019, filed 11 Feb 2020.